Literature DB >> 23237315

Vascular risk factors and depression in later life: a systematic review and meta-analysis.

Vyara Valkanova1, Klaus P Ebmeier.   

Abstract

Reports of the association between cardiovascular risk factors and depression in later life are inconsistent; to establish the nature of their association seems important for prevention and treatment of late-life depression. We searched MEDLINE, EMBASE, and PsycINFO for relevant cohort or case control studies over the last 22 years; 1097 were retrieved; 26 met inclusion criteria. Separate meta-analyses were performed for Risk Factor Composite Scores (RFCS) combining different subsets of risk factors, Framingham Stroke Risk Score, and single factors. We found a positive association (odds ratio [OR]: 1.49; 95% confidence interval [CI]: 1.27-1.75) between RFCS and late-life depression. There was no association between Framingham Stroke Risk Score (OR: 1.25; 95% CI: .99-1.57), hypertension (OR: 1.14; 95% CI: .94-1.40), or dyslipidemia (OR: 1.08; 95% CI: .91-1.28) and late-life depression. The association with smoking was weak (OR: 1.35; 95% CI: 1.00-1.81), whereas positive associations were found with diabetes (OR: 1.51; 95% CI: 1.30-1.76), cardiovascular disease (OR: 1.76; 95% CI: 1.52-2.04), and stroke (OR: 2.11; 95% CI: 1.61-2.77). Moderate to high heterogeneity was found in the results for RFCS, smoking, hypertension, dyslipidemia, and stroke, whereas publication bias was detected for RFCS and diabetes. We therefore found convincing evidence of a strong relationship between key diseases and depression (cardiovascular disease, diabetes, and stroke) and between composite vascular risk and depression but not between some vascular risk factors (hypertension, smoking, dyslipidemia) and depression. More evidence is needed to be accumulated from large longitudinal epidemiological studies, particularly if complemented by neuroimaging.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23237315     DOI: 10.1016/j.biopsych.2012.10.028

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

1.  The nuances of cognition and depression in older adults: the need for a comprehensive assessment.

Authors:  Patrick J Brown; Joel R Sneed; Bret R Rutherford; D P Devanand; Steven P Roose
Journal:  Int J Geriatr Psychiatry       Date:  2013-10-03       Impact factor: 3.485

2.  Cardiovascular risk and incidence of depression in young and older adults: evidence from the SUN cohort study.

Authors:  Patricio Molero; Miguel Ángel Martinez-Gonzalez; Miguel Ruiz-Canela; Francisca Lahortiga; Almudena Sánchez-Villegas; Aurora Perez-Cornago; Alfredo Gea
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

Review 3.  Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?

Authors:  Ryan Abbott; Donald D Chang; Harris A Eyre; Chad A Bousman; David A Merrill; Helen Lavretsky
Journal:  Am J Geriatr Psychiatry       Date:  2017-05-25       Impact factor: 4.105

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 5.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

6.  A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis.

Authors:  Shang Ma; Devi Santhosh; Peeyush Kumar T; Zhen Huang
Journal:  Dev Cell       Date:  2017-05-22       Impact factor: 12.270

7.  Antidepressant Treatment for Late-Life Depression: Considering Risks and Benefits.

Authors:  Eric J Lenze; Hanadi Ajam Oughli
Journal:  J Am Geriatr Soc       Date:  2019-05-29       Impact factor: 5.562

Review 8.  Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?

Authors:  Montserrat Serra-Millàs
Journal:  World J Psychiatry       Date:  2016-03-22

9.  Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.

Authors:  Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein
Journal:  J Clin Psychiatry       Date:  2018-10-23       Impact factor: 4.384

Review 10.  Late-life depression in the primary care setting: challenges, collaborative care, and prevention.

Authors:  Charles A Hall; Charles F Reynolds-Iii
Journal:  Maturitas       Date:  2014-06-07       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.